Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2017 2
2018 2
2020 5
2021 4
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Younger Brazilians hit by COVID-19 - What are the implications?
Guimarães RM, Portela MC, Villela DAM, Correa Matta G, de Freitas CM. Guimarães RM, et al. Among authors: villela dam. Lancet Reg Health Am. 2021 Sep;1:100014. doi: 10.1016/j.lana.2021.100014. Epub 2021 Jul 14. Lancet Reg Health Am. 2021. PMID: 34386787 Free PMC article. No abstract available.
Identification of priority groups for COVID-19 vaccination in Brazil.
Lana RM, Freitas LP, Codeço CT, Pacheco AG, Carvalho LMF, Villela DAM, Coelho FC, Cruz OG, Niquini RP, Porto VBG, Gava C, Gomes MFDC, Bastos LS. Lana RM, et al. Among authors: villela dam. Cad Saude Publica. 2021 Oct 8;37(10):e00049821. doi: 10.1590/0102-311X00049821. eCollection 2021. Cad Saude Publica. 2021. PMID: 34644749 Free article. English, Portuguese.
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Valim V, Martins-Filho OA, Gouvea MDPG, Camacho LAB, Villela DAM, de Lima SMB, Azevedo AS, Neto LFP, Domingues CMAS, de Medeiros Junior NF, Moulaz IR, Dias LH, Miyamoto ST, Teixeira-Carvalho A, Mill JG; Half Dose ChAdOx Study Group. Valim V, et al. Among authors: villela dam. Front Immunol. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416. eCollection 2022. Front Immunol. 2022. PMID: 36105814 Free PMC article. Clinical Trial.
The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study.
Santos CVBD, Valiati NCM, Noronha TG, Porto VBG, Pacheco AG, Freitas LP, Coelho FC, Gomes MFDC, Bastos LS, Cruz OG, Lana RM, Luz PM, Carvalho LMF, Werneck GL, Struchiner CJ, Villela DAM. Santos CVBD, et al. Among authors: villela dam. Lancet Reg Health Am. 2023 Apr;20:100465. doi: 10.1016/j.lana.2023.100465. Epub 2023 Mar 13. Lancet Reg Health Am. 2023. PMID: 36936517 Free PMC article.
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.
da Penha Gomes Gouvea M, Lira Machado KLL, de Oliveira YGP, Moulaz IR, Henriques AG, Gouveia TM, Thompson BP, Lança KEM, de Souza Ramos S, Lacerda GCC, Lenzi JPG, de Castro Pimentel F, Miossi JPM, Rassele ML, Camacho LAB, Villela DAM, de Lima SMB, de Souza Azevedo A, Horbach IS, de Araújo MF, Tort LFL, de Oliveira ACA, Siqueira MM, Garcia CC, da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, da Silva VG, Miyamoto ST, Dos Santos Fantoni RN, Pinto-Neto LF, Magda Domingues C, de Medeiros Junior NF, Burian AP, Teixeira-Carvalho A, Mota LMH, Mill JG, Martins-Filho OA, Valim V. da Penha Gomes Gouvea M, et al. Among authors: villela dam. Vaccine. 2023 Oct 20;41(44):6514-6528. doi: 10.1016/j.vaccine.2023.08.022. Epub 2023 Sep 1. Vaccine. 2023. PMID: 37661534
23 results